Background: Ascorbate (vitamin C) has long been used as an unorthodox therapy for cancer, even though the underlying scientific mechanisms are not well understood. Clinical Trial: A pilot phase 1/2a clinical trial was conducted in patients with newly diagnosed stage III or IV ovarian cancer.
At the Alternative Cancer Treatment Centre in Kehl, Dr. Hartung treats patients suffering from ovarian cancer by using intravenous, high-dose Vitamin C. The .
intravenous, but not oral, ascorbate produces millimolar concentrations both in blood and in tissues, killing ovarian cancer cells without harming normal.
Vitamin C has become the center of interest in cancer studies,. is that high-dose intravenous vitamin C (HDIVC) is greater than 10 g/infusion and low-dose. of arsenic trioxide in ovarian cancer cells; gemcitabine in pancreatic cancer cells; .
I was diagnosed with ovarian cancer in June 2011. To date I have had 5 courses of chemotherapy to control the disease. There seems to be no .
Intravenous vitamin C (IVC) is a contentious adjunctive cancer therapy, widely used. chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy.